Clinical Trial

Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV

Study acronym: ATTACH-Scale
Recruiting
View on ClinicalTrials.gov →
Summary
Ending the HIV epidemic for youth living with HIV will require implementation and optimization of evidence-based interventions that address barriers to treatment. The proposed implementation study will test a youth-led data-driven implementation strategy to scale-up an evidence-based Adolescent Transition Package (ATP) aimed at improving transition processes and post-transition clinical outcomes for youth living with HIV in Kenya. Clinics will be randomized to receive standard of care implementation through trainer of trainers or the youth-led data-driven implementation strategy alongside trainer of trainers. We will study whether the enhanced implementation strategy improves the number of youth who receive the ATP, the number of providers that initially chose to use the ATP, and the consistency with which the ATP is used over time. We will also evaluate the cost of the ATP and whether the ATP improves health outcomes among youth living with HIV, including viral suppression and retention in care. Healthcare workers at study sites will complete surveys, focus group discussions, interviews, and participate in continuous quality improvement processes. Youth will participate in surveys and focus groups, and have their routine medical records abstracted.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-04; most recent amendment 2025-11-12.
Status change: Not Yet Recruiting → Recruiting 2025-11-12
Trial Details
NCT Number NCT06924073
Lead Sponsor University of Washington
Collaborators: National Institute of Mental Health (NIMH), Kenyatta National Hospital, University of Nairobi, Kenya
Conditions Adolescent HIV Infection, Transition to Adult Care, Implementation Science, Implementation Strategies
Enrollment 1,920 participants
Start Date 2025-10-16
Primary Completion 2029-01-30 (estimated)
Study Completion 2029-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-14